Erratum: Gastric changes following colchicine therapy in patients with FMF (Dig Dis Sci (2008) 53 (2079-2082) (DOI 10.1007/s10620-007-0132-7));Gastric changes following colchicine therapy in patients with FMF

Digestive Diseases and Sciences

Volumn 53, Issue 8, 2008, Pages 2079-2082

  Al Daraji, Wael Ismail ^a   Al Mahmoud, Riham M W ^b   Ilyas, Mohammed ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Antrum; Colchicine; FMF; GI effects; Ring mitoses

Indexed keywords

COLCHICINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; MALE; PERITONITIS; PLEURISY; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH ANTRUM; TREATMENT RESPONSE;

EID: 46449084420     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0937-7     Document Type: Erratum

References (32)

1. Cazeneuve C, Ajrapetyan H, Papin S et al (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67:1136-1143
2. Cazeneuve C, Hovannesyan Z, Genevieve D et al (2003) Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum 48:2324-2331
3. Dode C, Hazenberg BP, Pecheux C et al (2002) Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks. Nephrol Dial Transplant 17:1212-1217
4. Booth DR, Gillmore JD, Booth SE et al (1998) Pyrin/marenostrin mutations in familial Mediterranean fever. Qjm 91:603-606
5. Booth DR, Gillmore JD, Lachmann HJ et al (2000) The genetic basis of autosomal dominant familial Mediterranean fever. Qjm 93:217-221
6. Booth DR, Lachmann HJ, Gillmore JD et al (2001) Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148. Qjm 94:527-531
7. Chen X, Bykhovskaya Y, Tidow N et al (2000) The familial Mediterranean fever protein interacts and colocalizes with a putative Golgi transporter. Proc Soc Exp Biol Med 224:32-40
8. Al-Alami JR, Tayeh MK, Najib DA et al (2003) Familial Mediterranean fever mutation frequencies and carrier rates among a mixed Arabic population. Saudi Med J 24:1055-1059
9. Livneh A, Aksentijevich I, Langevitz P et al (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD). Eur J Hum Genet 9:191-196
10. Livneh A, Langevitz P, Shinar Y et al (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6:1-6
11. Settin A, El-Baz R, Abd Rasool M et al (2007) Clinical and molecular diagnosis of familial Mediterranean fever in Egyptian children. J Gastrointestin Liver Dis 16:141-145
12. Andreu JM, Timasheff SN (1982) Interaction of tubulin with single ring analogues of colchicine. Biochemistry 21:534-543
13. Anilkumar TV, Sarraf CE, Hunt T et al (1992) The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br J Cancer 65:552-558
14. Stern N, Kupferschmidt H, Meier-Abt PJ (1997) [Follow-up and therapy of acute colchicine poisoning]. Schweiz Rundsch Med Prax 86:952-956
15. Webb DI, Chodos RB, Mahar CQ et al (1968) Mechanism of vitamin B12 malabsorption in patients receiving colchicine. N Engl J Med 279:845-850
16. Ben-Chetrit E (2003) Familial Mediterranean fever (FMF) and renal AA amyloidosis-phenotype-genotype correlation, treatment and prognosis. J Nephrol 16:431-434
17. Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behcet's disease-are they associated? J Rheumatol 29:530-534
18. Ben-Chetrit E, Lerer I, Malamud E et al (2000) The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? Hum Mutat 15:385-386
19. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum (1998)28:48-59
20. Ben-Chetrit E, Levy M (2001) Enigmas in familial Mediterranean fever (FMF). Clin Exp Rheumatol 19: S1-S5
21. Ben-Chetrit E, Urieli-Shoval S, Calko S et al (2002) Molecular diagnosis of FMF: lessons from a study of 446 unrelated individuals. Clin Exp Rheumatol 20: S25-S29
22. Iacobuzio-Donahue CA, Lee EL, Abraham SC et al (2001) Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol 25:1067-1073
23. Parfitt JR, Driman DK (2007) Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol 38:527-536
24. Hruban RH, Yardley JH, Donehower RC et al (1989) Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer 63:1944-1950
25. Tishler RB, Lamppu DM, Park S et al (1995) Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res 55:6021-6025
26. Debernardis D, Sire EG, De Feudis P et al (1997) p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res 57:870-874
27. Woods CM, Zhu J, McQueney PA et al (1995) Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1:506-526
28. Torres K, Horwitz SB (1998) Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res 58:3620-3626
29. Haldar S, Chintapalli J, Croce CM (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253-1255
30. Stemmermann GN, Hayashi T (1971) Colchicine intoxication. A reappraisal of its pathology based on a study of three fatal cases. Hum Pathol 2:321-332
31. Hart J, Lewin KJ, Peters RS et al (1993) Effect of long-term colchicine therapy on jejunal mucosa. Dig Dis Sci 38:2017-2021
32. Race TF, Paes IC, Faloon WW (1970) Intestinal malabsorption induced by oral colchicine. Comparison with neomycin and cathartic agents. Am J Med Sci 259:32-41